Hemidesmosome integrity protects the colon against colitis and colorectal cancer

Gut

Volumn 66, Issue 10, 2017, Pages 1748-1760

  De Arcangelis, Adèle ^a,b,c   Hamade, Hussein ^a,b,c,d   Alpy, Fabien ^a,b,c,e   Normand, Sylvain ^f   Bruyère, Emilie ^g   Lefebvre, Olivier ^a,b,h   Méchine Neuville, Agnès ^b,i,j   Siebert, Stéphanie ^a,b,c   Pfister, Véronique ^a,b,c   Lepage, Patricia ^k   Laquerriere, Patrice ^a,l   Dembele, Doulaye ^a,b,c   Delanoye Crespin, Anne ^f   Rodius, Sophie ^a,b,c,m   Robine, Sylvie ^c,n   Kedinger, Michèle ^a,b   Van Seuningen, Isabelle ^g   Simon Assmann, Patricia ^a,b,h   Chamaillard, Mathias ^f   Labouesse, Michel ^a,b,c,o   Georges Labouesse, Elisabeth ^a,b,c   more..

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSERM   (France)

^c CNRS   (France)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^f INSTITUT PASTEUR DE LILLE   (France)

^g UNIV LILLE   (France)

^h FMTS Fédération de Médecine Translationnelle de Strasbourg   (France)

ⁱ HÔPITAL DE HAUTEPIERRE   (France)

^j INSTITUT BERGONIÉ   (France)

^k UNIVERSITÉ PARIS SACLAY   (France)

^l INSTITUT DE RECHERCHES SUBATOMIQUES   (France)

^m NorLux Neuro Oncology Laboratory   (Luxembourg)

ⁿ INSTITUT CURIE   (France)

^o Département de Biologie   (France)

more..

Author keywords

CELL MATRIX INTERACTION; COLORECTAL CANCER; IBD; INTEGRINS; INTESTINAL BARRIER FUNCTION

Indexed keywords

ALPHA6BETA4 INTEGRIN; ANTIBIOTIC AGENT; CD11B ANTIGEN; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LAMININ; ALPHA6 INTEGRIN; CYTOKERATIN 18; CYTOKERATIN 8; CYTOKINE; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE ACTIVATION; BASEMENT MEMBRANE; BONE MARROW CELL; COLITIS; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; HEMIDESMOSOME; HYPERPLASIA; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH; ADAPTIVE IMMUNITY; ADENOCARCINOMA; ANIMAL; B LYMPHOCYTE; COLORECTAL TUMOR; EPITHELIUM CELL; GENETICS; HOMEOSTASIS; INTESTINE MUCOSA; LYMPHOCYTE ACTIVATION; METABOLISM; MUCUS; PATHOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ADENOCARCINOMA; ANIMALS; B-LYMPHOCYTES; BASEMENT MEMBRANE; CASPASE 1; COLITIS; COLORECTAL NEOPLASMS; CYTOKINES; EPITHELIAL CELLS; HEMIDESMOSOMES; HOMEOSTASIS; INTEGRIN ALPHA6; INTEGRIN ALPHA6BETA4; INTESTINAL MUCOSA; KERATIN-18; KERATIN-8; LYMPHOCYTE ACTIVATION; MICE; MUCUS; MYELOID DIFFERENTIATION FACTOR 88; PERMEABILITY; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84977488245     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-310847     Document Type: Article

References (54)

1. McGuckin MA, Eri R, Simms LA, et al. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 2009;15:100-13.
2. Okamoto R, Watanabe M. Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease. J Gastroenterol 2016;51:11-21.
3. Salim SY, Söderholm JD. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis 2010;17:362-81.
4. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009;361:2066-78.
5. Grivennikov SI. Inflammation and colorectal cancer: Colitis-associated neoplasia. Semin Immunopathol 2013;35:229-44.
6. Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011;140:1807-16.
7. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010;28:573-621.
8. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011;474:298-306.
9. Spenlé C, Hussenet T, Lacroute J, et al. Dysregulation of laminins in intestinal inflammation. Pathol Biol 2012;60:41-7.
10. Nievers MG, Schaapveld RQ, Sonnenberg A. Biology and function of hemidesmosomes. Matrix Biol 1999;18:5-17.
11. Stutzmann J, Bellissent-Waydelich A, Fontao L, et al. Adhesion complexes implicated in intestinal epithelial cell-matrix interactions. Microsc Res Tech 2000;51:179-90.
12. Barrett JC, Lee JC, Lees CW, et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 2009;41:1330-4.
13. Thompson AI, Lees CW. Genetics of ulcerative colitis. Inflamm Bowel Dis 2011;17:831-48.
14. Peters U, Jiao S, Schumacher FR, et al. Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology 2013;144:799-807.e24.
15. Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: Part I. Epithelial associated tissues. J Am Acad Dermatol 2009;61:367-84; quiz 385-6.
16. Huang BL, Chandra S, Shih DQ. Skin manifestations of inflammatory bowel disease. Front Physiol 2012;3:13.
17. Niculescu C, Ganguli-Indra G, Pfister V, et al. Conditional ablation of integrin alpha-6 in mouse epidermis leads to skin fragility and inflammation. Eur J Cell Biol 2011;90:270-7.
18. el Marjou F, Janssen KP, Chang BH, et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 2004;39:186-93.
19. Dowling J, Yu QC, Fuchs E. Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol 1996;134:559-72.
20. Georges-Labouesse E, Messaddeq N, Yehia G, et al. Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice. Nat Genet 1996;13:370-3.
21. van der Neut R, Krimpenfort P, Calafat J, et al. Epithelial detachment due to absence of hemidesmosomes in integrin beta 4 null mice. Nat Genet 1996;13:366-9.
22. Raul F, Simon P, Kedinger M, et al. Intestinal enzymes activities in isolated villus and crypt cells during postnatal development of the rat. Cell Tissue Res 1977;176:167-78.
23. Toedter G, Li K, Sague S, et al. Genes associated with intestinal permeability in ulcerative colitis: Changes in expression following infliximab therapy. Inflamm Bowel Dis 2012;18:1399-410.
24. Mombaerts P, Iacomini J, Johnson RS, et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992;68:869-77.
25. Tourneur E, Chassin C. Neonatal immune adaptation of the gut and its role during infections. Clin Dev Immunol 2013;2013:270301.
26. Sheng YH, Hasnain SZ, Florin TH, et al. Mucins in inflammatory bowel diseases and colorectal cancer. J Gastroenterol Hepatol 2012;27:28-38.
27. Nowarski R, Jackson R, Gagliani N, et al. Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis. Cell 2015;163:1444-56.
28. Toivola DM, Krishnan S, Binder HJ, et al. Keratins modulate colonocyte electrolyte transport via protein mistargeting. J Cell Biol 2004;164:911-21.
29. Johansson ME, Gustafsson JK, Holmén-Larsson J, et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 2014; 63:281-91.
30. Larmonier CB, Laubitz D, Hill FM, et al. Reduced colonic microbial diversity is associated with colitis in NHE3-deficient mice. Am J Physiol Gastrointest Liver Physiol 2013;305:G667-77.
31. Xiao F, Yu Q, Li J, et al. Slc26a3 deficiency is associated with loss of colonic HCO3 (-) secretion, absence of a firm mucus layer and barrier impairment in mice. Acta Physiol (Oxf ) 2014;211:161-75.
32. Vaishnava S, Yamamoto M, Severson KM, et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 2011;334:255-8.
33. Kanneganti M, Mino-Kenudson M, Mizoguchi E. Animal models of colitis-associated carcinogenesis. J Biomed Biotechnol 2011;2011:342637.
34. Miyazaki K. Laminin-5 (laminin-332): Unique biological activity and role in tumor growth and invasion. Cancer Sci 2006;97:91-8.
35. Said AH, Raufman JP, Xie G. The role of matrix metalloproteinases in colorectal cancer. Cancers (Basel) 2014;6:366-75.
36. West NR, McCuaig S, Franchini F, et al. Emerging cytokine networks in colorectal cancer. Nat Rev Immunol 2015;15:615-29.
37. Rodius S, Indra G, Thibault C, et al. Loss of alpha6 integrins in keratinocytes leads to an increase in TGFbeta and AP1 signaling and in expression of differentiation genes. J Cell Physiol 2007;212:439-49.
38. Giancotti FG. Targeting integrin beta4 for cancer and anti-angiogenic therapy. Trends Pharmacol Sci 2007;28:506-11.
39. Jones RG, Li X, Gray PD, et al. Conditional deletion of beta1 integrins in the intestinal epithelium causes a loss of Hedgehog expression, intestinal hyperplasia, and early postnatal lethality. J Cell Biol 2006;175:505-14.
40. Ussar S, Moser M, Widmaier M, et al. Loss of Kindlin-1 causes skin atrophy and lethal neonatal intestinal epithelial dysfunction. PLoS Genet 2008;4:e1000289.
41. Lachaux A, Bouvier R, Loras-Duclaux I, et al. Isolated deficient alpha6beta4 integrin expression in the gut associated with intractable diarrhea. J Pediatr Gastroenterol Nutr 1999;29:395-401.
42. Zhang Y, Li W, Li L, et al. Structural damage in the C. elegans epidermis causes release of STA-2 and induction of an innate immune response. Immunity 2015;42:309-20.
43. Fu J, Wei B, Wen T, et al. Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J Clin Invest 2011;121:1657-66.
44. Specian RD, Neutra MR. Cytoskeleton of intestinal goblet cells in rabbit and monkey. The theca. Gastroenterology 1984;87:1313-25.
45. Huber S, Gagliani N, Zenewicz LA, et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 2012;491:259-63.
46. Kirchberger S, Royston DJ, Boulard O, et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 2013;210:917-31.
47. Liu J, Duan Y, Cheng X, et al. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun 2011;407:348-54.
48. Baribault H, Penner J, Iozzo RV, et al. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev 1994;8:2964-73.
49. Habtezion A, Toivola DM, Butcher EC, et al. Keratin-8-deficient mice develop chronic spontaneous Th2 colitis amenable to antibiotic treatment. J Cell Sci 2005;118:1971-80.
50. Habtezion A, Toivola DM, Asghar MN, et al. Absence of keratin 8 confers a paradoxical microflora-dependent resistance to apoptosis in the colon. Proc Natl Acad Sci USA 2011;108:1445-50.
51. Guo W, Pylayeva Y, Pepe A, et al. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 2006;126:489-502.
52. Stewart RL, O'Connor KL. Clinical significance of the integrin 64 in human malignancies. Lab Invest 2015;95:976-86.
53. Raymond K, Kreft M, Song JY, et al. Dual Role of alpha6beta4 integrin in epidermal tumor growth: Tumor-suppressive versus tumor-promoting function. Mol Biol Cell 2007;18:4210-21.
54. Zhang H, Landmann F, Zahreddine H, et al. A tension-induced mechanotransduction pathway promotes epithelial morphogenesis. Nature 2011;471:99-103.